These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 28640531)
21. Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma. Kim SY; Kim EK; Moon HJ; Yoon JH; Koo JS; Kim SG; Kim MJ Magn Reson Imaging; 2018 Dec; 54():176-182. PubMed ID: 30172938 [TBL] [Abstract][Full Text] [Related]
22. Association between Oncotype DX recurrence score and dynamic contrast-enhanced MRI features in patients with estrogen receptor-positive HER2-negative invasive breast cancer. Kim HJ; Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY Clin Imaging; 2021 Jul; 75():131-137. PubMed ID: 33548871 [TBL] [Abstract][Full Text] [Related]
23. Histogram analysis of apparent diffusion coefficient at 3.0t: Correlation with prognostic factors and subtypes of invasive ductal carcinoma. Kim EJ; Kim SH; Park GE; Kang BJ; Song BJ; Kim YJ; Lee D; Ahn H; Kim I; Son YH; Grimm R J Magn Reson Imaging; 2015 Dec; 42(6):1666-78. PubMed ID: 25919239 [TBL] [Abstract][Full Text] [Related]
24. Early-stage invasive ductal carcinoma: Association of tumor apparent diffusion coefficient values with axillary lymph node metastasis. Kim JY; Seo HB; Park S; Moon JI; Lee JW; Lee NK; Lee SW; Bae YT Eur J Radiol; 2015 Nov; 84(11):2137-43. PubMed ID: 26318821 [TBL] [Abstract][Full Text] [Related]
25. Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient. Suo S; Zhang K; Cao M; Suo X; Hua J; Geng X; Chen J; Zhuang Z; Ji X; Lu Q; Wang H; Xu J J Magn Reson Imaging; 2016 Apr; 43(4):894-902. PubMed ID: 26343918 [TBL] [Abstract][Full Text] [Related]
26. Prediction of Low versus High Recurrence Scores in Estrogen Receptor-Positive, Lymph Node-Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores. Dialani V; Gaur S; Mehta TS; Venkataraman S; Fein-Zachary V; Phillips J; Brook A; Slanetz PJ Radiology; 2016 Aug; 280(2):370-8. PubMed ID: 26937802 [TBL] [Abstract][Full Text] [Related]
27. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps. Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388 [TBL] [Abstract][Full Text] [Related]
28. Association of DW/DCE-MRI features with prognostic factors in breast cancer. Shao G; Fan L; Zhang J; Dai G; Xie T Int J Biol Markers; 2017 Mar; 32(1):e118-e125. PubMed ID: 27646773 [TBL] [Abstract][Full Text] [Related]
29. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging. Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380 [TBL] [Abstract][Full Text] [Related]
30. Qualitative Radiogenomics: Association between Oncotype DX Test Recurrence Score and BI-RADS Mammographic and Breast MR Imaging Features. Woodard GA; Ray KM; Joe BN; Price ER Radiology; 2018 Jan; 286(1):60-70. PubMed ID: 28885890 [TBL] [Abstract][Full Text] [Related]
31. Can Diffusion-Weighted Imaging and Related Apparent Diffusion Coefficient be a Prognostic Value in Women With Breast Cancer? Rabasco P; Caivano R; Simeon V; Dinardo G; Lotumolo A; Gioioso M; Villonio A; Iannelli G; D'Antuono F; Zandolino A; Macarini L; Guglielmi G; Cammarota A Cancer Invest; 2017 Feb; 35(2):92-99. PubMed ID: 28107084 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Oncotype DX Recurrence Score by Histologic Types of Breast Carcinoma. Bomeisl PE; Thompson CL; Harris LN; Gilmore HL Arch Pathol Lab Med; 2015 Dec; 139(12):1546-9. PubMed ID: 26619027 [TBL] [Abstract][Full Text] [Related]
33. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging. Suo S; Zhang D; Cheng F; Cao M; Hua J; Lu J; Xu J Eur Radiol; 2019 Mar; 29(3):1425-1434. PubMed ID: 30116958 [TBL] [Abstract][Full Text] [Related]
34. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes. Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778 [TBL] [Abstract][Full Text] [Related]
35. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors. Razek AA; Gaballa G; Denewer A; Nada N NMR Biomed; 2010 Jul; 23(6):619-23. PubMed ID: 20232453 [TBL] [Abstract][Full Text] [Related]
36. Correlation between 3T apparent diffusion coefficient values and grading of invasive breast carcinoma. Cipolla V; Santucci D; Guerrieri D; Drudi FM; Meggiorini ML; de Felice C Eur J Radiol; 2014 Dec; 83(12):2144-2150. PubMed ID: 25305145 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer. Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006 [TBL] [Abstract][Full Text] [Related]
38. Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative breast cancers? Yepes MM; Romilly AP; Collado-Mesa F; Net JM; Kiszonas R; Arheart KL; Young D; Glück S Breast Cancer Res Treat; 2014 Nov; 148(1):117-23. PubMed ID: 25262341 [TBL] [Abstract][Full Text] [Related]
39. Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma. Kitajima K; Yamano T; Fukushima K; Miyoshi Y; Hirota S; Kawanaka Y; Miya M; Doi H; Yamakado K; Hirota S Eur J Radiol; 2016 May; 85(5):943-9. PubMed ID: 27130054 [TBL] [Abstract][Full Text] [Related]